NWKHY Quote, Financials, Valuation and Earnings

Aspen Pharmacare Holdings has a net margin of -- compared to Netcare's net margin of --. Netcare's return on equity of 13.51% beat Aspen Pharmacare Holdings's return on equity of 5.16%.

Netcare has a consensus price target of --, signalling downside risk potential of --. On the other hand Aspen Pharmacare Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Netcare has higher upside potential than Aspen Pharmacare Holdings, analysts believe Netcare is more attractive than Aspen Pharmacare Holdings.

Netcare has a beta of 0.083, which suggesting that the stock is 91.675% less volatile than S&P 500. In comparison Aspen Pharmacare Holdings has a beta of 1.121, suggesting its more volatile than the S&P 500 by 12.142%.

Netcare has a quarterly dividend of $0.16 per share corresponding to a yield of 4.5%. Aspen Pharmacare Holdings offers a yield of 2.24% to investors and pays a quarterly dividend of $0.21 per share. Netcare pays -- of its earnings as a dividend. Aspen Pharmacare Holdings pays out 34.63% of its earnings as a dividend. Aspen Pharmacare Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Netcare quarterly revenues are --, which are smaller than Aspen Pharmacare Holdings quarterly revenues of --. Netcare's net income of -- is lower than Aspen Pharmacare Holdings's net income of --. Notably, Netcare's price-to-earnings ratio is 13.17x while Aspen Pharmacare Holdings's PE ratio is 15.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Netcare is 0.74x versus 1.72x for Aspen Pharmacare Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Clicks Group has a net margin of -- compared to Netcare's net margin of --. Netcare's return on equity of 13.51% beat Clicks Group's return on equity of 48.74%.

Netcare has a consensus price target of --, signalling downside risk potential of --. On the other hand Clicks Group has an analysts' consensus of -- which suggests that it could fall by --. Given that Netcare has higher upside potential than Clicks Group, analysts believe Netcare is more attractive than Clicks Group.

Netcare has a beta of 0.083, which suggesting that the stock is 91.675% less volatile than S&P 500. In comparison Clicks Group has a beta of 0.763, suggesting its less volatile than the S&P 500 by 23.696%.

Netcare has a quarterly dividend of $0.16 per share corresponding to a yield of 4.5%. Clicks Group offers a yield of 1.89% to investors and pays a quarterly dividend of $0.23 per share. Netcare pays -- of its earnings as a dividend. Clicks Group pays out -- of its earnings as a dividend.

Netcare quarterly revenues are --, which are smaller than Clicks Group quarterly revenues of --. Netcare's net income of -- is lower than Clicks Group's net income of --. Notably, Netcare's price-to-earnings ratio is 13.17x while Clicks Group's PE ratio is 31.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Netcare is 0.74x versus 1.94x for Clicks Group. Usually stocks with elevated PS ratios are considered overvalued.

Life Healthcare Group Holdings has a net margin of -- compared to Netcare's net margin of --. Netcare's return on equity of 13.51% beat Life Healthcare Group Holdings's return on equity of 30.26%.

Netcare has a consensus price target of --, signalling downside risk potential of --. On the other hand Life Healthcare Group Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Netcare has higher upside potential than Life Healthcare Group Holdings, analysts believe Netcare is more attractive than Life Healthcare Group Holdings.

Netcare has a beta of 0.083, which suggesting that the stock is 91.675% less volatile than S&P 500. In comparison Life Healthcare Group Holdings has a beta of 0.804, suggesting its less volatile than the S&P 500 by 19.635%.

Netcare has a quarterly dividend of $0.16 per share corresponding to a yield of 4.5%. Life Healthcare Group Holdings offers a yield of 3.12% to investors and pays a quarterly dividend of $0.07 per share. Netcare pays -- of its earnings as a dividend. Life Healthcare Group Holdings pays out 196.23% of its earnings as a dividend.

Netcare quarterly revenues are --, which are smaller than Life Healthcare Group Holdings quarterly revenues of --. Netcare's net income of -- is lower than Life Healthcare Group Holdings's net income of --. Notably, Netcare's price-to-earnings ratio is 13.17x while Life Healthcare Group Holdings's PE ratio is 5.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Netcare is 0.74x versus 0.93x for Life Healthcare Group Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Institute of Biomedical Research has a net margin of -- compared to Netcare's net margin of --. Netcare's return on equity of 13.51% beat Institute of Biomedical Research's return on equity of --.

Netcare has a consensus price target of --, signalling downside risk potential of --. On the other hand Institute of Biomedical Research has an analysts' consensus of -- which suggests that it could fall by --. Given that Netcare has higher upside potential than Institute of Biomedical Research, analysts believe Netcare is more attractive than Institute of Biomedical Research.

Netcare has a beta of 0.083, which suggesting that the stock is 91.675% less volatile than S&P 500. In comparison Institute of Biomedical Research has a beta of 2.581, suggesting its more volatile than the S&P 500 by 158.057%.

Netcare has a quarterly dividend of $0.16 per share corresponding to a yield of 4.5%. Institute of Biomedical Research offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Netcare pays -- of its earnings as a dividend. Institute of Biomedical Research pays out -- of its earnings as a dividend.

Netcare quarterly revenues are --, which are smaller than Institute of Biomedical Research quarterly revenues of --. Netcare's net income of -- is lower than Institute of Biomedical Research's net income of --. Notably, Netcare's price-to-earnings ratio is 13.17x while Institute of Biomedical Research's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Netcare is 0.74x versus -- for Institute of Biomedical Research. Usually stocks with elevated PS ratios are considered overvalued.